Examining Progress and Future Directions in Follicular Lymphoma Treatment
Researchers examine how far follicular lymphoma treatment has come, what limitations still remain, and where the management of the disease is headed.
Lymphoma
LYMPHOMA ADVISOR
FEATURED CONTENT
-
-
Diagnosing and Managing Patients With Primary Pancreatic Lymphoma
Because primary pancreatic lymphoma is a rare disease, optimal diagnostic and therapeutic protocols have not yet been established. -
Could Checkpoint Blockade Be Useful in Non-Hodgkin Lymphoma After All?
A study suggested that the immunotherapy could be sensitizing non-Hodgkin lymphoma patients to subsequent therapies. -
Has the Time for At-Home Cancer Care Finally Come?
A Penn Medicine team debuts its program focused on cancer care at home — just in time for COVID-19. -
Early-Memory T-Cell Population May Predict CAR-T Efficacy in Several Hematological Malignancies
Enrichment of an early memory CD8+ T-cell phenotype in patients’ blood was predictive of their response to CAR-T therapy in CLL, NHL, and MM.
VIDEO SERIES
LYMPHOMA NEWS
Two Trials Evaluate CAR-T Cell Therapy for Relapsed/Refractory Hodgkin Lymphoma
High Molecular Response With Lenalidomide, Rituximab in Untreated Follicular Lymphoma
First CAR T-Cell Therapy Approved for Mantle Cell Lymphoma
Allogeneic-HSCT Outcomes With Varied Donor Sources in Adult T-Cell Leukemia/Lymphoma
PET-Based Treatment Approach for Diffuse Large B-Cell Lymphoma
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Lymphoma
